HOOKIPA Biotech GmbH

HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical stage biopharmaceutical company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body’s immune system. At HOOKIPA we are united by a set of core values and common beliefs which give meaning to our work and guide our daily behaviour. How…